Concern over Nipah virus cases amidst the COVID‐19 pandemic in India

Authors: Abdullahi T. Aborode, Andrew A. Wireko, Aashna Mehta, Toufik Abdul‐Rahman, Esther P. Nansubuga, Mrinmoy Kundu, Manas Pustake, Qasim Mehmood, H. Tillewein

Year: 2022

Journal: Journal of Medical Virology

DOI: 10.1002/jmv.27745

Summary

This letter discusses the concern over Nipah virus cases in India during the COVID-19 pandemic and the lack of specific pharmacological treatment for Nipah virus.

Key Findings

Nipah virus is a zoonotic infection that can be transmitted by direct contact with infected animals or via bodily secretions such as bat blood, saliva, and urine.
The virus affects the central nervous system in human hosts, causing inflammation of brain parenchyma (encephalitis) and respiratory symptoms.
Nipah virus has been designated a global epidemic by the WHO due to its high fatality rate, highly contagious nature, potential for human exposure, and lack of a vaccine.
The diversity of surroundings and hosts may further accelerate the mutation rate of RNA viruses, explaining new cases in pandemics such as COVID-19.

Methodology

Study Type: Letter to the Editor
Geographic Focus: India

Topics

Nipah virus, Zoonotic infections, Epidemiology, Public health

Relevance

The paper highlights the concern over Nipah virus cases in India during the COVID-19 pandemic, which could strain public health resources and necessitate early diagnosis and management.

Source

View the entire paper: File:JMV-94-3488.pdf